ProThera Biologics and Takeda Enter Global Licensing Agreement to Develop Novel Plasma-Derived Therapy Based on Inter-alpha Inhibitor Proteins (IAIP)

Providence, R.I., and Osaka, JAPAN, April 23, 2020 – ProThera Biologics, Inc. and Takeda Pharmaceutical Company Limited [TSE:4502/NYSE:TAK] (“Takeda”) today announced that they have entered into a global licensing agreement to develop a novel plasma-derived...

FCC Chair Proposes $200 Million COVID-19 Telehealth Grant Program

March 31, 2020 3:44AM ET (Inside Health Policy) The Federal Communications Commission Chair Ajit Pai on Monday (March 30) proposed using $200 million allocated by Congress for a grant program for hospitals and health system providers aiming to use telehealth in their...